Treatment A + Treatment B + Treatment C
Phase 1Completed 0 watching 0 views this week๐ค Quiet
30
Development Stage
โ
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Vasomotor Symptoms
Conditions
Vasomotor Symptoms
Trial Timeline
Nov 5, 2025 โ Jan 14, 2026
NCT ID
NCT07229404About Treatment A + Treatment B + Treatment C
Treatment A + Treatment B + Treatment C is a phase 1 stage product being developed by Bayer for Vasomotor Symptoms. The current trial status is completed. This product is registered under clinical trial identifier NCT07229404. Target conditions include Vasomotor Symptoms.
Hype Score Breakdown
Clinical
10
Activity
5
Company
7
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT07229404 | Phase 1 | Completed |
Competing Products
20 competing products in Vasomotor Symptoms